20
Divis Laboratories Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is GABAPENTIN USP, with a corresponding US DMF Number 19000.
Remarkably, this DMF maintains an Active status since its submission on December 04, 2005, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 16, 2015, and payment made on December 10, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II